MoonLake Immunotherapeutics' Sonelokimab's Phase 3 trials, PsA market growth, and Merck's $3B bid showcase potential. Read my ...

The latest addition to The Woodlands’ life sciences core is open for business, and it could attract more businesses to the ...

Groundbreaking results from AstraZeneca’s Phase III SERENA-6 trial reveal a significant leap forward in the treatment of ...

While vepdegestrant outperformed a standard treatment option in a subtype of patients, the benefit on progression-free ...

28,921 people played the daily Crossword recently. Can you solve it faster than others?28,921 people played the daily Crossword recently. Can you solve it faster than others?

A Massachusetts-based wound care and sports medicine company announced plans for its brand-new biomanufacturing facility Tuesday in Smithfield. Trump administration issues major COVID vaccine ...

This summary is reviewed by TRD Staff. Chicago's life-sciences market is struggling, with a 43.3 percent vacancy rate for biotech labs, which is double the average of leading U.S. markets.

Biotechnology company Regeneron will acquire ... using this data to pursue discoveries that benefit science and society," Aris Baras, senior vice president and head of the Regeneron Genetics ...

This example of success demonstrates what's possible when life sciences companies partner with a banking team that has offered continuity and specialized expertise for over a decade: sustainable ...

biotechnology, and life sciences. Previously, he served as Business Development Director, Diagnostics at Dana-Farber Cancer Institute, and held senior positions at Foundation Medicine and Roche ...